Application and validation of a computerized cough acquisition system for objective monitoring of acute cough - A meta-analysis

被引:90
作者
Pavesi, L [1 ]
Subburaj, S [1 ]
Porter-Shaw, K [1 ]
机构
[1] Procter & Gamble Tech Ctr, Clin Dev Dept, Staines TW18 3AZ, Middx, England
关键词
acute cough; antitussive; computerized objective measure; cough effort; cough frequency; cough intensity; cough latency; dextromethorphan; metes-analysis;
D O I
10.1378/chest.120.4.1121
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Study objective: The purpose of the metes-analysis was to understand the antitussive effect of treatment with dextromethorphan hydrobromide, 30 mg, vs placebo over a 3-h treatment period in patients with cough due to uncomplicated upper respiratory, tract infection (URTI), and to show that the computerized system for acquisition and analysis of cough sound was consistent and reproducible across the individual studies. Study design: The sit studies used for the metes-analysis were randomized, double-blind, parallel-group, single-close, placebo-controlled studies with a 3-h postdose cough evaluation period. Setting: One study was conducted in Durban, South Africa, and five studies were conducted in Bombay, India. Four studies took place in clinics, and two studies were in-home studies. Patients: Seven hundred ten adult patients with cough due to uncomplicated URTI who were otherwise healthy and who satisfied the inclusion/exclusion criteria for the metes-analysis. Measurements and results: For each patient, a standard baseline was calculated pretreatment, then a 3-h continuous cough recording was made after treatment was initiated. Five efficacy variables were measured in 30-min intervals: cough bouts, cough components, cough effort, cough intensity, and cough latency. The metes-analysis showed consistent results across most of the studies for each of the efficacy, variables. It demonstrated significantly greater overall reductions in cough bouts, cough components, and cough effort, and an increase in cough latency for patients treated with dextromethorphan hydrobromide, 30 mg, vs those treated with placebo. Conclusion: The results of a metes-analysis of the six clinical studies show that the antitussive effect of a single dose of dextromethorphan hydrobromide, 30 mg, has been established. The consistent nature of the results shows that the computerized cough acquisition and analysis system is a valid and reproducible methodology for evaluating cough associated with URTI.
引用
收藏
页码:1121 / 1128
页数:8
相关论文
共 20 条
[1]  
ALTMAN DG, 1991, PRACTICAL STAT MED R, P431
[2]  
AYLWARD M, 1984, EUR J RESPIR DIS, V65, P283
[3]   COUGH - PHYSIOLOGY, EVALUATION, AND TREATMENT [J].
BANNER, AS .
LUNG, 1986, 164 (02) :79-92
[4]   Efficacy and tolerability of levodropropizine in adult patients with non-productive cough. Comparison with dextromethorphan [J].
Catena, E ;
Daffonchio, L .
PULMONARY PHARMACOLOGY & THERAPEUTICS, 1997, 10 (02) :89-96
[5]  
Croughan-Minihane M S, 1993, J Am Board Fam Pract, V6, P109
[6]   Codeine, cough and upper respiratory infection [J].
Eccles, R .
PULMONARY PHARMACOLOGY & THERAPEUTICS, 1996, 9 (5-6) :293-297
[7]   COMPARISON OF THE ANTITUSSIVE EFFECTS OF CODEINE PHOSPHATE 20 MG, DEXTROMETHORPHAN 30 MG AND NOSCAPINE 30 MG USING CITRIC ACID-INDUCED COUGH IN NORMAL SUBJECTS [J].
EMPEY, DW ;
LAITINEN, LA ;
YOUNG, GA ;
BYE, CE ;
HUGHES, DTD .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 16 (06) :393-397
[8]   HIGH-DOSE DEXTROMETHORPHAN IN AMYOTROPHIC-LATERAL-SCLEROSIS - PHASE-I SAFETY AND PHARMACOKINETIC STUDIES [J].
HOLLANDER, D ;
PRADAS, J ;
KAPLAN, R ;
MCLEOD, HL ;
EVANS, WE ;
MUNSAT, TL .
ANNALS OF NEUROLOGY, 1994, 36 (06) :920-924
[9]  
IRWIN RS, 1987, EUR J RESP DIS S, V71, P73
[10]   ANTITUSSIVE EFFECT OF DEXTROMETHORPHAN AND DEXTROMETHORPHAN-SALBUTAMOL COMBINATION IN HEALTHY-VOLUNTEERS WITH ARTIFICIALLY INDUCED COUGH [J].
KARTTUNEN, P ;
TUKIAINEN, H ;
SILVASTI, M ;
KOLONEN, S .
RESPIRATION, 1987, 52 (01) :49-53